[1] ZHAO R, ZHAO W, HUANG J, et al. Prevalence and Risk Factors of Peri-Implant Disease: A Retrospective Case-Control Study in Western China. Int J Environ Res Public Health. 2022;19(19):12667.
[2] IVANOVSKI S, BARTOLD PM, HUANG YS. The role of foreign body response in peri‐implantitis: What is the evidence? Periodontol 2000. 2022;90(1):176-185.
[3] SHUTO T, WACHI T, SHINOHARA Y, et al. Increase in receptor activator of nuclear factor κB ligand/osteoprotegerin ratio in peri-implant gingiva exposed to Porphyromonas gingivalis lipopolysaccharide. J Dent Sci. 2016;11(1):8-16.
[4] INSUA A, MONJE A, WANG HL, et al. Basis of bone metabolism around dental implants during osseointegration and peri‐implant bone loss. J Biomed Mater Res A. 2017;105(7):2075-2089.
[5] FU X, LIU G, HALIM A, et al. Mesenchymal stem cell migration and tissue repair. Cells. 2019; 8(8):784.
[6] SONG W, BO X, MA X, et al. Craniomaxillofacial derived bone marrow mesenchymal stem/stromal cells (BMSCs) for craniomaxillofacial bone tissue engineering: A literature review. J Stomatol Oral Maxillofac Surg. 2022;123(6):e650-e659.
[7] TONIOLO L, CONCATO M, GIACOMELLO E. Resveratrol, a multitasking molecule that improves skeletal muscle health. Nutrients. 2023; 15(15):3413.
[8] HECKER A, SCHELLNEGGER M, HOFMANN E, et al. The impact of resveratrol on skin wound healing, scarring, and aging. Int Wound J. 2022;19(1):9-28.
[9] MEYER C, BROCKMUELLER A, RUIZ DE PORRAS V, et al. Microbiota and Resveratrol: How Are They Linked to Osteoporosis? Cells. 2024; 13(13):1145.
[10] YANG G, CHANG CC, YANG Y, et al. Resveratrol Alleviates Rheumatoid Arthritis via Reducing ROS and Inflammation, Inhibiting MAPK Signaling Pathways, and Suppressing Angiogenesis. J Agric Food Chem. 2018;66(49):12953-12960.
[11] ZHOU T, YAN Y, ZHAO C, et al. Resveratrol improves osteogenic differentiation of senescent bone mesenchymal stem cells through inhibiting endogenous reactive oxygen species production via AMPK activation. Redox Rep. 2019;24(1):62-69.
[12] MOLEZ AM, DO NASCIMENTO EHL, HAITER NETO F, et al. Effect of resveratrol on the progression of experimental periodontitis in an ovariectomized rat model of osteoporosis: Morphometric, immune-enzymatic, and gene expression analysis. J Periodontal Res. 2020;55(6):840-849.
[13] HERRERA D, BERGLUNDH T, SCHWARZ F, et al. Prevention and treatment of peri-implant diseases-The EFP S3 level clinical practice guideline. J Clin Periodontol. 2023;50 Suppl 26:4-76.
[14] MEYLE J, FISCHER-WASELS L. Non-surgical treatment of peri-implantitis. Br Dent J. 2024;237(10):780-785.
[15] SCHWARZ F, JEPSEN S, OBREJA K, et al. Surgical therapy of peri-implantitis. Periodontol 2000. 2022;88(1):145-181.
[16] FU JH, WANG HL. Breaking the wave of peri-implantitis. Periodontol 2000. 2020;84(1):145-160.
[17] BERGLUNDH T, ARMITAGE G, ARAUJO MG, et al. Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018;89 Suppl 1:S313-S318.
[18] DAVIES JE. Understanding peri‐implant endosseous healing. J Dent Educ. 2003;67(8):932-949.
[19] REIS FN, PELÁ VT, CÂMARA JVF, et al. A new role for resveratrol: Protection of enamel against erosion. J Dent. 2024;141:104810.
[20] GUO R, PENG W, YANG H, et al. Evaluation of resveratrol-doped adhesive with advanced dentin bond durability. J Dent. 2021;114: 103817.
[21] FARHAD SZ, KARBALAEIHASANESFAHANI A, DADGAR E, et al. Promising potential effects of resveratrol on oral and dental health maintenance: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(2):1367-1389.
[22] MENG T, XIAO D, MUHAMMED A, et al. Anti-inflammatory action and mechanisms of resveratrol. Molecules. 2021;26(1):229.
[23] LI Z, XU Y, LU S, et al. Bone mesenchymal stem cell extracellular vesicles delivered miR let-7-5p alleviate endothelial glycocalyx degradation and leakage via targeting ABL2. Cell Commun Signal. 2023;21(1):205.
[24] 岳海云,孙银雪,毕迎春.白藜芦醇促进人乳牙牙髓干细胞的增殖和成骨分化[J].中国组织工程研究,2023,27(19):3011-3016.
[25] YUAN J, WANG X, MA D, et al. Resveratrol rescues TNF‑α‑induced inhibition of osteogenesis in human periodontal ligament stem cells via the ERK1/2 pathway. Mol Med Rep. 2020;21(5):2085-2094.
[26] LI YY, CAI Q, LI BS, et al. The Effect of Porphyromonas gingivalis Lipopolysaccharide on the Pyroptosis of Gingival Fibroblasts. Inflammation. 2021;44(3):846-858.
[27] LIU J, HAN X, ZHANG T, et al. Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: from mechanism to therapy. J Hematol Oncol. 2023;16(1):116.
[28] IANTOMASI T, ROMAGNOLI C, PALMINI G, et al. Oxidative Stress and Inflammation in Osteoporosis: Molecular Mechanisms Involved and the Relationship with microRNAs. Int J Mol Sci. 2023;24(4):3772.
[29] ZHAO Y, SONG S, WANG D, et al. Nanozyme-reinforced hydrogel as a H2O2-driven oxygenerator for enhancing prosthetic interface osseointegration in rheumatoid arthritis therapy. Nat Commun. 2022;13(1):6758.
[30] ZENG L, HE H, SUN M, et al. Runx2 and Nell-1 in dental follicle progenitor cells regulate bone remodeling and tooth eruption. Stem Cell Res Ther. 2022;13(1):486.
[31] KOMORI T, YAGI H, NOMURA S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997;89(5):755-764.
[32] LIU X, YANG B, ZHANG Y, et al. miR-30a-5p inhibits osteogenesis and promotes periodontitis by targeting Runx2. BMC Oral Health. 2021;21(1):513.
[33] NAKASHIMA K, ZHOU X, KUNKEL G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 2002;108(1):17-29.
[34] CHEN S, GLUHAK-HEINRICH J, WANG Y, et al. Runx2, osx, and dspp in tooth development. J Dent Res. 2009;88(10):904-909.
[35] ZHOU F, YI Z, WU Y, et al. The role of forkhead box class O1 during implant osseointegration. Eur J Oral Sci. 2021;129(6):e12822.
[36] EBRAHIMNEZHAD M, NATAMI M, BAKHTIARI GH, et al. FOXO1, a tiny protein with intricate interactions: Promising therapeutic candidate in lung cancer. Biomed Pharmacother. 2023;169:115900.
[37] RACHED MT, KODE A, XU L, et al. FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts. Cell Metab. 2010;11(2):147-160.
[38] LIANG X, SU Y, HUO Y. Forkhead box protein O1 (FoxO1) /SERPINB1 ameliorates ROS production in diabetic nephropathy. Food Sci Nutr. 2020;9(1):44-51.
[39] XIONG Y, ZHANG Y, ZHOU F, et al. FOXO1 differentially regulates bone formation in young and aged mice. Cell Signal. 2022;99:110438.
[40] ZHAO H, QIN L, WANG R, et al. FOXO1 regulates NLRP3 inflammasome proteins in LPS-induced cardiotoxicity. Am J Transl Res. 2023;15(8):5446.
[41] HUANG X, SU X, MA Q, et al. FoxO1 agonists promote bone regeneration in periodontitis by protecting the osteogenesis of periodontal ligament stem cells. Stem Cells Dev. 2023;32(15-16): 491-503.
|